News

Those who climb indoors are doing something for their health. But climbing shoes contain chemicals of concern that can enter the lungs of climbers through the abrasion of the soles. A climbing ...
Concerning chemicals from the wear of climbing shoes cause trouble in indoor halls Concentrations as high as those by a busy road illustrate the importance of solutions Date: April 29, 2025 Source ...
Those who climb indoors are doing something for their health. But climbing shoes contain chemicals of concern that can enter the lungs of climbers through the abrasion of the soles. In a recent study, ...
SOUTH SAN FRANCISCO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...
Tenaya Therapeutics, Inc. announced that it will present five abstracts at the American Society of Gene and Cell Therapy's 28th Annual Meeting from May 13-17, 2025, in New Orleans. The ...
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...
Enrollment in Cohort 2 was initiated in December 2024 at the 6E13 vg/kg dose. Tenaya is on track to complete enrollment of Cohort 2 in the first half of 2025 and anticipates releasing initial ...
All products featured on Self are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. There’s a lot ...
The customer loved that the MTL MQM had “more versatility” than the typical climbing brand’s approach shoes. Grab the Merrell MTL MQM shoes for $90 while you can. The orange and blue version ...
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...